EE9900113A - Alendronate liquid formulations - Google Patents

Alendronate liquid formulations

Info

Publication number: EE9900113A
Authority: EE; Estonia
Prior art keywords: alendronate; liquid formulations; formulations; liquid; alendronate liquid
Prior art date: 1996-10-04

Application number

EEP199900113A

Other languages

Estonian (et)

Other versions

EE03669B1 (en

Inventor

J. Nerurkar Maneesh

A. Hunke William

Ostovic Drazen

Original Assignee

Merck & Co., Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-10-04

Filing date

1997-10-02

Publication date

1999-10-15

1997-01-13 Priority claimed from GBGB9700541.7A external-priority patent/GB9700541D0/en

1997-10-02 Application filed by Merck & Co., Inc. filed Critical Merck & Co., Inc.

1999-10-15 Publication of EE9900113A publication Critical patent/EE9900113A/en

2002-04-15 Publication of EE03669B1 publication Critical patent/EE03669B1/en

Links

OGSPWJRAVKPPFI-UHFFFAOYSA-N Alendronic Acid Chemical compound NCCCC(O)(P(O)(O)=O)P(O)(O)=O OGSPWJRAVKPPFI-UHFFFAOYSA-N 0.000 title 1
229940062527 alendronate Drugs 0.000 title 1
239000012669 liquid formulation Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Physical Education & Sports Medicine (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Rheumatology (AREA)
Epidemiology (AREA)
Orthopedic Medicine & Surgery (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

EEP199900113A 1996-10-04 1997-10-02 Liquid alendronate preparations and method of preparation EE03669B1 (en)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US2676596P	1996-10-04	1996-10-04
GBGB9700541.7A GB9700541D0 (en)	1997-01-13	1997-01-13	Liquid alendronate formulation
US3600297P	1997-01-22	1997-01-22
PCT/US1997/015740 WO1998014196A1 (en)	1996-10-04	1997-10-02	Liquid alendronate formulations

Publications (2)

Publication Number	Publication Date
EE9900113A true EE9900113A (en)	1999-10-15
EE03669B1 EE03669B1 (en)	2002-04-15

Family

ID=27268667

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EEP199900113A EE03669B1 (en)	1996-10-04	1997-10-02	Liquid alendronate preparations and method of preparation

Country Status (20)

Country	Link
EP (1)	EP1007054A4 (en)
JP (1)	JP2001501222A (en)
CN (1)	CN1238691A (en)
AU (1)	AU723357B2 (en)
BG (1)	BG103306A (en)
BR (1)	BR9712197A (en)
CA (1)	CA2267370A1 (en)
CZ (1)	CZ116999A3 (en)
EA (1)	EA001213B1 (en)
EE (1)	EE03669B1 (en)
HU (1)	HUP0000125A3 (en)
IL (1)	IL129127A0 (en)
IS (1)	IS5012A (en)
NO (1)	NO991569L (en)
NZ (1)	NZ334836A (en)
PL (1)	PL332496A1 (en)
SK (1)	SK42999A3 (en)
TR (1)	TR199900730T2 (en)
WO (1)	WO1998014196A1 (en)
YU (1)	YU17499A (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7560490B2 (en) *	2001-01-23	2009-07-14	Gador S.A.	Composition comprising bisphosphonates for prevention and/or treatment of metabolic diseases of bones, process for preparing such composition and use thereof
US20080286359A1 (en)	2004-05-24	2008-11-20	Richard John Dansereau	Low Dosage Forms Of Risedronate Or Its Salts
US20080287400A1 (en)	2004-05-24	2008-11-20	Richard John Dansereau	Low Dosage Forms Of Risedronate Or Its Salts
US7645459B2 (en)	2004-05-24	2010-01-12	The Procter & Gamble Company	Dosage forms of bisphosphonates
US7645460B2 (en)	2004-05-24	2010-01-12	The Procter & Gamble Company	Dosage forms of risedronate
US7473684B2 (en)	2005-09-16	2009-01-06	Selamine Limited	Bisphosphonate formulation
WO2007031785A2 (en) *	2005-09-16	2007-03-22	Selamine Ltd	Bisphosphonate formulation
JP2010043119A (en) *	2009-10-16	2010-02-25	Gador Sa	Composition for preventing and/or treating bone metabolic disease, method of preparing the same and use thereof
US8568747B1 (en)	2012-10-05	2013-10-29	Silvergate Pharmaceuticals, Inc.	Enalapril compositions
US9463183B1 (en)	2015-10-30	2016-10-11	Silvergate Pharmaceuticals, Inc.	Lisinopril formulations
US9669008B1 (en)	2016-03-18	2017-06-06	Silvergate Pharmaceuticals, Inc.	Enalapril formulations

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4206209A (en) *	1978-11-02	1980-06-03	Kracauer Paul	Sublingual aspirin tablet
IT1201087B (en) *	1982-04-15	1989-01-27	Gentili Ist Spa	PHARMACOLOGICALLY ACTIVE BIPPHOSPHONES, PROCEDURE FOR THEIR PREPARATION AND RELATED PHARMACEUTICAL COMPOSITIONS
US4922007A (en) *	1989-06-09	1990-05-01	Merck & Co., Inc.	Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid or salts thereof
US5019651A (en) *	1990-06-20	1991-05-28	Merck & Co., Inc.	Process for preparing 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid (ABP) or salts thereof
US5270365A (en) *	1991-12-17	1993-12-14	Merck & Co., Inc.	Prevention and treatment of periodontal disease with alendronate
US5358941A (en) *	1992-12-02	1994-10-25	Merck & Co., Inc.	Dry mix formulation for bisphosphonic acids with lactose
FR2703590B1 (en) *	1993-04-05	1995-06-30	Sanofi Elf	USE OF BISPHOSPHONIC ACID DERIVATIVES FOR THE PREPARATION OF MEDICINES FOR PROMOTING BONE REPAIR.
US5510517A (en) *	1993-08-25	1996-04-23	Merck & Co., Inc.	Process for producing N-amino-1-hydroxy-alkylidene-1,1-bisphosphonic acids
US5462932A (en) *	1994-05-17	1995-10-31	Merck & Co., Inc.	Oral liquid alendronate formulations
US5780455A (en) *	1994-08-24	1998-07-14	Merck & Co., Inc.	Intravenous alendronate formulations
US5616571A (en) *	1995-06-06	1997-04-01	Merck & Co., Inc.	Bisphosphonates prevent bone loss associated with immunosuppressive therapy

1997
- 1997-10-02 IL IL12912797A patent/IL129127A0/en unknown
- 1997-10-02 CN CN97180165A patent/CN1238691A/en active Pending
- 1997-10-02 WO PCT/US1997/015740 patent/WO1998014196A1/en not_active Ceased
- 1997-10-02 TR TR1999/00730T patent/TR199900730T2/en unknown
- 1997-10-02 CZ CZ991169A patent/CZ116999A3/en unknown
- 1997-10-02 EE EEP199900113A patent/EE03669B1/en not_active IP Right Cessation
- 1997-10-02 SK SK429-99A patent/SK42999A3/en unknown
- 1997-10-02 JP JP10516541A patent/JP2001501222A/en active Pending
- 1997-10-02 CA CA002267370A patent/CA2267370A1/en not_active Abandoned
- 1997-10-02 HU HU0000125A patent/HUP0000125A3/en unknown
- 1997-10-02 NZ NZ334836A patent/NZ334836A/en unknown
- 1997-10-02 AU AU46448/97A patent/AU723357B2/en not_active Ceased
- 1997-10-02 PL PL97332496A patent/PL332496A1/en unknown
- 1997-10-02 BR BR9712197-5A patent/BR9712197A/en unknown
- 1997-10-02 EP EP97945195A patent/EP1007054A4/en not_active Withdrawn
- 1997-10-02 EA EA199900352A patent/EA001213B1/en not_active IP Right Cessation
1999
- 1999-03-26 IS IS5012A patent/IS5012A/en unknown
- 1999-03-30 NO NO991569A patent/NO991569L/en not_active Application Discontinuation
- 1999-03-31 YU YU17499A patent/YU17499A/en unknown
- 1999-04-02 BG BG103306A patent/BG103306A/en unknown

Also Published As

Publication number	Publication date
IS5012A (en)	1999-03-26
WO1998014196A1 (en)	1998-04-09
AU4644897A (en)	1998-04-24
JP2001501222A (en)	2001-01-30
EE03669B1 (en)	2002-04-15
CN1238691A (en)	1999-12-15
EA001213B1 (en)	2000-12-25
SK42999A3 (en)	2000-01-18
AU723357B2 (en)	2000-08-24
BG103306A (en)	2000-01-31
EA199900352A1 (en)	1999-08-26
NO991569L (en)	1999-06-04
PL332496A1 (en)	1999-09-13
CZ116999A3 (en)	1999-09-15
IL129127A0 (en)	2000-02-17
NZ334836A (en)	2000-11-24
NO991569D0 (en)	1999-03-30
TR199900730T2 (en)	1999-07-21
YU17499A (en)	1999-11-22
HUP0000125A3 (en)	2001-04-28
BR9712197A (en)	1999-08-31
EP1007054A4 (en)	2000-07-19
HUP0000125A2 (en)	2000-06-28
CA2267370A1 (en)	1998-04-09
EP1007054A1 (en)	2000-06-14

Legal Events

Date	Code	Title	Description
2003-02-17	KB4A	Valid patent at the end of a year	Effective date: 20021231
2004-02-16	KB4A	Valid patent at the end of a year	Effective date: 20031231
2004-06-15	MM4A	Lapsed by not paying the annual fees	Effective date: 20031002

Publication	Publication Date	Title
DK0853945T3 (en)	2003-08-04	Liquid gonadotropin-containing formulations
FI964593L (en)	1996-11-15	Oral liquid alendronate formulations
MA24473A1 (en)	1998-10-01	FORMULATIONS
NO20001631L (en)	2000-05-30	2-methyl-thieno-benzodiazepine formulation
DE69715421D1 (en)	2002-10-17	CONCENTRATED LIQUID MICROBICIDE COMPOSITIONS
DE69732239D1 (en)	2005-02-17	LIQUID FAT-CONTAINING COMPOSITION
FI970603A7 (en)	1997-02-12	Liquid immunoglobulin formulations
DE69836513D1 (en)	2007-01-11	Thermo-optical devices
NO985294D0 (en)	1998-11-13	contrast agents
DE69718276D1 (en)	2003-02-13	fixing
ATA181095A (en)	1998-11-15	PROBIOTALLY EFFECTIVE FORMULATION
NO983828D0 (en)	1998-08-20	Imaging agents
DE59711705D1 (en)	2004-07-15	NEW INSECTICIDE FORMULATIONS
DE69710315D1 (en)	2002-03-21	LIQUID CLEANER
EE9900113A (en)	1999-10-15	Alendronate liquid formulations
ITMI951395A0 (en)	1995-06-29	F-SILICONE FORMULATIONS
ID16781A (en)	1997-11-13	PHARMACEUTICAL FORMULATIONS
ITMI941169A0 (en)	1994-06-06	PHARMACEUTICAL FORMULATIONS
EP0837863A4 (en)	1999-06-16	DINATRIUMALENDRONATE FORMULATIONS
ID20565A (en)	1999-01-14	GUIDELINES FOR LIQUID CONTINUOUSLY
ATE176985T1 (en)	1999-03-15	NEW LIQUID FORMULATIONS
NO991430L (en)	1999-03-24	Insecticide formulations
DE69916615D1 (en)	2004-05-27	LIQUID FORMULATION
DE69709700D1 (en)	2002-02-21	CONTRAST AGENTS
ID22385A (en)	1999-10-07	LIQUID ALENDRONATE FORMULATIONS